FCM
EXAS

Fieldview Capital Management’s Exact Sciences EXAS Stock Holding History

Fieldview Capital Management’s Portfolio EXAS Stock Details EXAS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-26,207
Closed -$2.66M – 560
2025
Q4 		$2.66M Buy
26,207
+20,501
+359% +$1.65M 0.45% 67
2025
Q3 		$312K Sell
5,706
-4,583
-45% -$229K 0.05% 326
2025
Q2 		$547K Buy
10,289
+2,180
+27% +$111K 0.08% 241
2025
Q1 		$351K Buy
8,109
+4,203
+108% +$213K 0.05% 321
2024
Q4 		$219K Buy
+3,906
New +$243K 0.03% 392

Other funds holding EXAS

VanEck Associates
VanEck Associates New York $133B AUM 72.99% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
PRS
Pinkerton Retirement Specialists Coeur D Alene, Idaho $1.1B AUM 30.57% 1-Year Est. Return
PWMAG
Pinnacle Wealth Management Advisory Group Red Bank, New Jersey $1.46B AUM 22.77% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return
BC
Broadwater Capital Boston, Massachusetts $138M AUM 28.86% 1-Year Est. Return

Fieldview Capital Management's EXAS Position: Q1 2026 in Review

Fieldview Capital Management sold out of Exact Sciences (EXAS) in Q1 2026, closing a stake of 26,207 shares — an estimated $2.66M sold.

Fieldview Capital Management first reported a position in EXAS in Q4 2024 and held it in 5 quarters. The position peaked at $2.66M in Q4 2025. 7 funds tracked by Wall St. Rank hold EXAS as of Q1 2026.

  • Fieldview Capital Management reported no remaining Exact Sciences position as of Q1 2026 after selling out during the quarter.
  • Fieldview Capital Management sold 26,207 Exact Sciences shares in Q1 2026, an estimated $2.66M.
  • Fieldview Capital Management first reported a position in Exact Sciences in Q4 2024 and held it in 5 quarters.
  • Fieldview Capital Management's Exact Sciences position peaked at $2.66M in Q4 2025.
  • 7 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2026.

Based on Fieldview Capital Management's 13F filing for Q1 2026, filed 14 May 2026.